Nuclear Medicine: Page 51

Lantheus revenue plummets 23% in Q2

By AuntMinnie.com staff writers

The parent company of Lantheus Medical Imaging posted a significant drop in revenue and swung to a net loss for the second quarter of 2020 due to the COVID-19 pandemic.

July 29, 2020

Clarity begins trial for pediatric neuroblastoma therapy

By AuntMinnie.com staff writers

Radiopharmaceutical firm Clarity Pharmaceuticals has begun recruitment for a phase I/IIA clinical trial evaluating its SARTATE peptide receptor radionuclide therapy for pediatric patients with neuroblastoma.

July 22, 2020

Clarity, ImaginAb team to develop theranostic agents

By AuntMinnie.com staff writers

Radiopharmaceutical firm Clarity Pharmaceuticals and imaging agent developer ImaginAb are collaborating to develop new targeted theranostic products for a range of cancer types.

July 20, 2020

SNMMI 2020: PSMA-PET/CT changes prostate cancer management

By Kate Madden Yee

PET/CT imaging with an F-18 DCFPyL prostate-specific membrane antigen (PSMA) radiopharmaceutical changed prostate cancer management in two-thirds of cases, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 14, 2020

SNMMI 2020: AI can aid in diagnosis of Parkinson's disease

By Erik L. Ridley

An artificial intelligence (AI) algorithm was highly accurate for diagnosing Parkinson's disease on dopamine transporter SPECT exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

July 13, 2020

SNMMI taps leaders for 2020-2021 year

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has tapped its leadership slate for the 2020-2021 year at this week's virtual conference.

July 13, 2020

SNMMI 2020: How nuclear medicine handled COVID-19

By Wayne Forrest

Implementing a proactive, multipronged strategy to combat the COVID-19 pandemic helped Mount Sinai Hospital safeguard its patients and staff as much as humanly possible, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 13, 2020

SNMMI 2020: Medical students key to the specialty's future

By Wayne Forrest

The early recruitment of medical students into nuclear medicine and molecular imaging is the key to the specialty's future, said Dr. Vasken Dilsizian during his president's address on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual annual meeting.

July 12, 2020

Spectrum Dynamics debuts new cardiac SPECT system

By AuntMinnie.com staff writers

Molecular imaging technology developer Spectrum Dynamics Medical has introduced D-SPECT Vista, a digital solid-state cadmium zinc telluride-based cardiac SPECT system.

July 9, 2020

CereHealth highlights population template at SNMMI 2020

By AuntMinnie.com staff writers

Artificial intelligence software developer CereHealth will present study data on a population template for CereMetrix, the company's brain SPECT imaging software, at the virtual 2020 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

July 9, 2020

BWXT appoints new president for BWXT ITG Canada

By AuntMinnie.com staff writers

U.S. government nuclear components supplier BWX Technologies (BWXT) has hired nuclear medicine industry veteran Martyn Coombs to be president of its BWXT ITG Canada medical radioisotope division, effective July 20.

July 6, 2020

New radioisotope works better for certain cancers

By AuntMinnie.com staff writers

A new radiopharmaceutical has shown better imaging performance in tumor detection, staging, and restaging for neuroendocrine cancer patients with liver metastases than another imaging agent, according to research published in the June issue of the Journal of Nuclear Medicine.

June 28, 2020

Previous Page

Page 51 of 445

Next Page